RVA is pleased to welcome the Turnbull Government’s announcement that ended the long-standing uncertainty regarding the Review of the Life Saving Drugs Program (LSDP). We commend the Government’s commitment to retain and improve the LSDP, drawing upon the recommendations of the Review. To read the Wilson Review Report, the Government’s response to the Report and FAQ, click here.
RVA’s initial response as published yesterday on our social media sites can be read here.
As many of you are aware, this has been a long and challenging issue. RVA thanks everyone involved for their persistence and dedication – you’ve all played an integral role in making the future brighter for rare disease patients in Australia!